Table 1.
Demographic, behavioral, and sexual health characteristics of community members associated with willingness to use doxycycline PrEP/PEP (n=212) – Southern California, 2020
| Study population |
Willing to use doxycycline PrEP/PEP |
||||
|---|---|---|---|---|---|
| n | % | n | % | p-value* | |
|
| |||||
| Age (years) | Median: 31, Range: 18–76 | ||||
| Gender | |||||
| Male | 204 | 96.2 | 136 | 66.7 | 0.45 |
| Trans women | 1 | 0.5 | 1 | 100.0 | |
| Other/Unknown ** | 7 | 3.3 | 6 | 85.7 | |
| Sexual Orientation | |||||
| Gay or homosexual | 179 | 84.4 | 117 | 65.4 | 0.15 |
| Bisexual | 27 | 12.7 | 20 | 74.1 | |
| Other/Unknown *** | 6 | 2.8 | 6 | 100.0 | |
| Ethnicity | |||||
| Hispanic or Latino/Latina/Latinx | 81 | 38.2 | 61 | 75.3 | 0.06 |
| Not Hispanic or Latino/Latina/Latinx | 130 | 61.3 | 82 | 63.1 | |
| Other/Unknown | 1 | 0.5 | 0 | 0.0 | |
| Race | |||||
| African American/Black American | 27 | 12.7 | 20 | 74.1 | 0.03 |
| American Indian/Alaskan Native | 1 | 0.5 | 1 | 100.0 | |
| Asian | 30 | 14.2 | 15 | 50.0 | |
| Caucasian/White | 84 | 39.6 | 62 | 73.8 | |
| Multiracial **** | 24 | 11.3 | 11 | 45.8 | |
| Other/Unknown | 46 | 21.7 | 34 | 73.9 | |
| County of Residence | |||||
| Los Angeles County | 133 | 62.7 | 90 | 67.7 | 0.55 |
| Riverside County | 31 | 14.6 | 23 | 74.2 | |
| Orange County | 21 | 9.9 | 11 | 52.4 | |
| San Diego County | 15 | 7.1 | 11 | 73.3 | |
| Other/Unknown | 12 | 5.7 | 8 | 66.7 | |
| Concerns about contracting STI | |||||
| Not at all concerned | 28 | 13.2 | 15 | 53.6 | <0.01 |
| Slightly concerned | 40 | 18.9 | 22 | 55.0 | |
| Somewhat concerned | 29 | 13.7 | 19 | 65.5 | |
| Moderately concerned | 57 | 26.9 | 40 | 70.2 | |
| Very concerned | 57 | 26.9 | 46 | 80.7 | |
| Did not answer | 1 | 0.5 | 1 | 100.0 | |
| Bacterial STI diagnosis in the last 12 months (n=211) | 73 | 34.4 | 62 | 84.9 | <0.01 |
| Frequency of condom use during anal sex | |||||
| Never | 66 | 31.1 | 42 | 63.6 | 0.55 |
| Sometimes | 94 | 44.3 | 67 | 71.3 | |
| Always | 33 | 15.6 | 20 | 60.6 | |
| No history of anal sex in the past 12 months | 19 | 9.0 | 14 | 73.7 | |
| HIV-infected ***** | 34 | 16.0 | 25 | 73.5 | 0.41 |
| Currently on HIV PrEP (n=178) | 70 | 33.0 | 57 | 81.4 | <0.01 |
| History of HIV PEP use (n=179) | 43 | 20.3 | 33 | 76.7 | 0.14 |
*
Based on Pearson’s χ2 test.
**
Includes non-binary, genderqueer, and unspecified.
***
Includes pansexual, queer, and unspecified.
****
Defined as participants who report two or more races.
*****
Categorization is based on responses regarding current HIV PrEP use.
STI, sexual transmitted infections; HIV, human immunodeficiency virus; PrEP, pre-exposure prophylaxis; PEP, post-exposure prophylaxis